Drug therapy offers high cure rate for 2 hepatitis C subtypes

A new drug is offering dramatic cure rates for hepatitis C patients with two subtypes of the infection -- genotype 2 and 3, say a team of scientists. The drug, called sofosbuvir, offers more effective treatment for most patients studied in a Phase 3 clinical trial who had no other treatment options, report researchers.

Read the whole article on Science Daily

More from Science Daily